Julie D. ShirkPatent & Trademark SpecialistSterne, Kessler, Goldstein & Fox P.L.L.C.Websitewww.skgf.com/Organization ProfileFull ProfileConnectEmailLinkedIn202-772-8632 Professional Biography Julie D. Shirk joined Sterne Kessler in 1989 and continues to specialize in patents and trademarks in the firm's Mechanical Group. More Legal and Business Bylines From Julie D. Shirk Registrability and Enforceability -- Look Beyond the Register to Determine Scope of Trademark Rights - (Posted On Sunday, August 03, 2014) Generic Top Level Domains - Current Sunrise Periods Open - August 2014 Update - (Posted On Saturday, August 02, 2014) An Expensive Reminder to Secure Trademark Rights Prior to Foreign Expansion - (Posted On Saturday, August 02, 2014) U.S. Patent and Trademark Office Proposes Fee Reductions - (Posted On Friday, June 27, 2014) FDA Draft Guidance - Best Practices for Developing Drug Trademarks - Food and Drug Administration - (Posted On Friday, June 27, 2014) Pagination Previous page ‹ Previous Page 3 Current Legal Analysis DOE Releases SAF Grand Challenge Roadmap Implementation Framework by: Lynn L. Bergeson , Carla N. Hutton California DFPI Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia FDA Extends Comment Deadline for Proposed Post-Market Assessment Approach by: Food and Drug Law at Keller and Heckman Understanding French Export and Re-Export Prohibitions: Ministry of Armed Forces Releases FAQ on Non Re-Exportation Certificates by: Sabine Naugès , Michal Chajdukowski New CFPB Larger Participant Rule Boosts Oversight of Major Digital Payment Providers by: A.J. S. Dhaliwal , Mehul N. Madia California Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 REACH 30/30 - 04 December 2024 Dec 5 2024 Home Care Industry Update Dec 5 2024 Annual Review: Non-compete and Trade Secret Protection for Employers Dec 11 2024 2025 Annual Reporting & Proxy Season Update Print
